Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GMP “Design Space” To Facilitate FDA Quality Initiative Implementation

This article was originally published in The Pink Sheet Daily

Executive Summary

“Design Space” is emerging as a pivotal concept in FDA’s effort to integrate its pharmaceutical application review and inspection operations into a new “quality assessment” system. With regulatory flexibility for manufacturing changes in the balance, the agency will be working with industry to refine the concept and its application in drug development and manufacturing.

You may also be interested in...

ICH Q9 Provides Implementation Framework For Quality Risk Management

ICH's quality risk management draft guideline "Q9" provides a common language and systematic approach that will facilitate industry/regulator communications. ICH Q9 is intended to provide a practical toolbox to accompany the pharmaceutical development ("Q8") and newly agreed to quality systems ("Q10") facets of the ICH effort to evolve a more harmonized and flexible quality oversight process.

FDA Creates CMC Pilots To Put Quality Assessment Principles Into Practice

NDA and ANDA pilot programs will help transform the way CMC information is submitted and reviewed by FDA. Office of Generic Drugs' white paper on "question-based review" follows the introduction of an NDA pilot program in mid-July.


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts